Orf virus encodes a novel secreted protein inhibitor of granulocyte- macrophage colony-stimulating factor and interleukin-2

Journal of Virology

Volumn 74, Issue 3, 2000, Pages 1313-1320

  Deane, David ^a   Mcinnes, Colin J ^a   Percival, Ann ^a   Wood, Ann ^a   Thomson, Jackie ^a   Lear, Andrea ^c   Gilray, Janice ^a   Fleming, Stephen ^b   Mercer, Andrew ^b   Haig, David ^a  

^a MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Astra Clinical Research Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNITY; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; REINFECTION; VIRUS GENE; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATTLE; CELLS, CULTURED; CHO CELLS; CHROMATOGRAPHY, GEL; CRICETINAE; DIMERIZATION; DNA, COMPLEMENTARY; ECTHYMA, CONTAGIOUS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-2; KERATINOCYTES; LYMPH; MOLECULAR SEQUENCE DATA; ORF VIRUS; RECOMBINANT PROTEINS; SHEEP; VIRAL PROTEINS;

EID: 0033958428     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.3.1313-1320.2000     Document Type: Article

References (65)

1. Alcamí, A., and G. L. Smith. 1992. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153-167.
2. Alcamí, A., and G. L. Smith. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69:4633-4639.
3. Brown, C. B., P. Beaudry, T. D. Laing, S. Shoemaker, and K. Kaushansky. 1995. In vitro characterisation of the human recombinant soluble granulocyte-macrophage colony-stimulating factor receptor. Blood 85:1488-1495.
4. Brown, C. B., C. E. Pihl, and E. W. Murray. 1997. Oligomerization of the soluble granulocyte-macrophage colony-stimulating factor receptor: identification of the functional ligand-binding species. Cytokine 9:219-225.
5. Bujdoso, R., D. Sargan, M. Williamson, and I. McConnell. 1992. Cloning of a cDNA encoding the ovine interleukin-2 receptor 55-kDa protein, CD25. Gene 113:283-284.
6. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
7. Cockett, M. I., C. R. Bebbington, and G. T. Yarrington. 1990. High level expression of tissue inhibitor metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification. Bio/Technology 8:662-667.
8. Colamonici, O. R., P. Domanski, S. M. Sweitzer, A. Larner, and R. M. L. Buller. 1995. Vaccinia virus B18R gene encodes a type 1 interferon-binding protein that blocks interferon-α transmembrane signalling. J. Biol. Chem. 270:15974-15978.
9. Cooper, J. A., and B. Moss. 1979. In vitro translation of immediate early, early and late classes of RNA from vaccinia virus-infected cells. Virology 96:368-380.
10. Davies, M. V., H.-W. Chang, B. L. Jacobs, and R. J. Kaufman. 1993. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67:1688-1692.
11. Dummer, R., G. Posseckert, K. Sugamura, H. Grundmann, and G. Burg. 1996. Circulating interleukin-2 receptors are a group of multimcric proteins with immunoreactivity for interleukin-2 receptor alpha, beta and gamma chains. J. Interferon Cytokine Res. 16:315-320.
12. Entrikan, G., D. M. Haig, and M. Norval. 1989. Identification of ovine interferons: differential activities derived from fibroblast and lymphoid cells. Vet. Immunol. Immunopathol. 21:187-195.
13. Entrican, G., D. Deane, M. MacLean, L. Inglis, J. Thomson, C. McInnes, and D. M. Haig. 1996. Development of a sandwich ELISA for ovine granulocyte macrophage-colony stimulating factor. Vet. Immunol. Immunopathol. 50:287-298.
14. Essani, K., S. Chalasani, R. Eversole, L. Beuving, and L. Birmingham. 1994. Multiple anti-cytokine activities secreted from tanapox virus-infected cells. Microb. Pathog. 17:347-353.
15. Farner, N. L., J. A. Hank, and P. M. Sondel. 1997. Interleukin-2: molecular and clinical aspects, p. 29-41. In D. G. Remick and J. S. Friedland (ed.), Cytokines in health and disease, 2nd ed. Marcel Dekker, Ann Arbor, Mich.
16. Fleming, S. B., C. A. McCaughan, A. E. Andrews, A. D. Nash, and A. A. Mercer. 1997. A homolog of interleukin-10 is encoded by the poxvirus orf virus. J. Virol. 71:4857-4861.
17. Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247-266.
18. Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:517-563
19. Haig, D. M., G. Hutchison, I. Green, D. Sargan, and H. W. Reid. 1995. The effect of intradermal injection of GM-CSF and TNF-α on the accumulation of dendritic cells in ovine skin. Vet. Dermatol. 6:211-220.
20. Haig, D. M., A. Percival, J. Mitchell, I. Green, and D. Sargan. 1995. The survival and growth of ovine afferent lymph dendritic cells in culture depends on tumour necrosis factor-α and is enhanced by granulocyte-macrophage colony-stimulating factor but inhibited hy interferon-γ. Vet. Immunol. Immunopathol. 45:221-236.
21. Haig, D. M., D. L. Deane, A. Percival, N. Myatt, J. Thomson, L. Inglis, J. Rothel, H.-F. Seow, P. Wood, H. R. P. Miller, and H. W. Reid. 1996. The cytokine response of afferent lymph following orf virus reinfection of sheep. Vet. Dermatol. 7:11-20.
22. + T cells during orf virus reinfection. J. Gen. Virol. 77:953-961.
23. - efferent lymph T cells after orf virus reinfection. J. Comp. Pathol. 115:163-174.
24. Haig, D. M., C. J. McInnes, G. Hutchison, H.-F. Seow, and H. W. Reid. 1996. Cyclosporin-A abrogates the acquired immunity to cutaneous reinfection with the parapoxvirus orf virus. Immunology 89:524-531.
25. Haig, D. M. 1997. Techniques for the culture of ovine haemopoietic cells, p. 2098-2106. In I. Lefkovits (ed.). Immunological methods manual, vol. 4. Academic Press, London, United Kingdom.
26. Haig, D. M., and A. Mercer. 1998. Ovine diseases. Orf. Vet. Res. 29:311-326.
27. Haig, D. M., C. J. McInnes, J. Thomson, A. Wood, K. Bunyan, and A. A. Mercer. 1998. The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase. Immunology 93:335-340.
28. Haig, D. M., J. Hopkins, and H. R. P. Miller. 1999. Local immune responses in afferent and efferent lymph. Immunology 96:155-163.
29. Heaney, M. L., J. C. Vera, M. A. Raines, and D. W. Golde. 1995. Membrane-associated and soluble granulocyte-macrophage colony-stimulating factor receptor alpha subunits are independently regulated in HL60 cells. Proc. Natl. Acad. Sci. USA 92:2365-2369.
30. Honda, M., K. Kitamura, T. Takeshita, K. Sugamura, and T. Tokunaga. 1990. Identification of a soluble IL-2 receptor beta chain from human lymphoid cell line cells. J. Immunol. 145:4131-4135.
31. Hu, F.-Q., C. A. Smith, and D. J. Pickup. 1994. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343-356.
32. Jenkinson, D. M., G. Hutchison, S. K. Onwuka, and H. W. Reid. 1991. Changes in the MHC class II dendritic cell population of ovine skin in response to orf virus infection. Vet. Dermatol. 2:1-9.
33. Jenkinson, D. M., G. Hutchison, and H. W. Reid. 1992. The B and T cell responses to orf virus infection of ovine skin. Vet. Dermatol. 3:57-64.
34. Kanakura, Y., H. Sugahara, H. Mitsui, H. Ikeda, T. Furitsu, H. Yagura, H. Kitayama, Y. Kanayama, and Y. Matsuzawa. 1993. Functional expression of interleukin-2 receptor in a human factor-dependent megakaryoblastic leukaemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin-2 binding to its receptor. Cancer Res. 53:675-680.
35. Lalani, A. S., and G. McFadden. 1997. Secreted poxvirus chemokine binding proteins. J. Leukoc. Biol. 62:570-576.
36. Lalani, A. S., K. Graham, K. Mossman, K. Rajarathnam, I. Clark-Lewis, D. Kelvin, and G. McFadden. 1997. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 71:4356-4363.
37. Lear, A. 1995. The characterisation of the ovine skin response to orf virus infection. Ph.D thesis. University of Edinburgh, Edinburgh, Scotland.
38. Lear, A., G. Hutchison, H. W. Reid, M. Norval, and D. M. Haig. 1996. Phenotypic characterization of the dendritic cells accumulating in the ovine dermis following primary and secondary orf virus infections. Eur. J. Dermatol. 6:135-140.
39. + T cells and a humoral immune response are important for the elimination of orf virus from the skin of sheep. Vet. Immunol. Immunopathol., in press.
40. Lyttle, D. J., K. M. Fraser, S. B. Fleming, A. A. Mercer, and A. J. Robinson. 1994. Homologs of vascular endothelial growth factor arc encoded by the poxvirus orf virus, J. Virol. 68:84-92.
41. Mahr, A., and B. E. Roberts. 1984. Arrangement of late RNAs transcribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment. J. Virol. 49:510-520.
42. McConahey, P. J., and F. J. Dixon. 1980. Radio-iodination of proteins by use of the chloramine-T method. Methods Enzymol. 70:210-213.
43. McInnes, C., D. Haig, and M. Logan. 1993. The cloning and expression of the gene for ovine interleukin-3 (multi-CSF) and a comparison of the in vitro hematopoietic activity of ovine IL-3 with ovine GM-CSF and human M-CSF. Exp. Hematol. 21:1528-1534.
44. McInnes, C. J., A. Wood, and A. A. Mercer. 1998. Orf virus encodes a gene with homology to the vaccinia virus interferon-resistance E3L gene. Virus Genes 17:107-115.
45. McKeever, D. J., and H. W. Reid. 1986. Survival of orf virus under British winter conditions. Vet. Rec. 118:613-614.
46. McNiece, I. 1997. Interleukin-3 and the colony-stimulating factors, p. 41-53. In D. G. Remick and J. S. Friedland (ed.), Cytokines in health and disease, 2nd ed. Marcel Dekker. Ann Arbor, Mich.
47. Mercer, A. A., K. Fraser, G. Barns, and A. J. Robinson. 1987. The structure and cloning of orf virus DNA. Virology 157:1-12.
48. Mercer, A. A., D. L. Yirrell, E. M. Whelan, P. F. Nettleton, I. Pow, J. A. Gilray, H. W. Reid, and A. J. Robinson. 1997. A novel strategy for determining protective antigens of the parapoxvirus orf virus. Virology 229:193-200.
49. Mercer, A. A., and D. M. Haig. 1999. Parapoxviruses p. 1140-1146. In A. Granoff and R. Webster (ed.), The encyclopaedia of virology, vol. 2. Academic Press, London, United Kingdom.
50. Mossman, K., C. Upton, and G. McFadden. 1995. The myxoma virus soluble interferon-γ receptor homolog, M-T7, inhibits interferon-γ in a species-specific manner. J. Biol. Chem. 270:3031-3038.
51. Park, L. S., U. Martin, R. Sorensen, S. Luhr, P. J. Morrissey, D. Cosman, and A. Larsen. 1992. Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc. Natl. Acad. Sci. USA 89:4295-4299.
52. Pye, D. 1990. Vaccination of sheep with cell culture grown orf virus. Aust. Vet. J. 67:182-186.
53. Raines, M. A., L. Liu, S. G. Quan, V. Joe, J. F. DiPersio, and D. W. Golde. 1991. Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. Proc. Natl. Acad. Sci. USA 88:8203-8207.
54. Smith, C. A., T. D. Smith. P. J. Smolak, D. Friend, H. Hagen, M. Gerhart, L. Park, D. J. Pickup, D. Torrance, K. Mohler, K. Schooley, and R. G. Goodwin. 1997. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236:316-327.
55. Smith, G. L., V. S. Chan, and S. T. Howard. 1991. Nucleotide sequence of 42kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J. Gen. Virol. 72:1349-1376.
56. Smith, G. L. 1996. Virus proteins that bind cytokines, chemokines or interferons. Curr. Opin. Immunol. 8:467-171.
57. Spriggs, M. K. 1996. One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 14:101-130.
58. Spriggs, M. K., D. E. Hruby, C. R. Maliszewski, D. J. Pickup, J. E. Sims, R. M. L. Buller, and J. Vansiyke. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145-152.
59. Strockbine, L. D., J. I. Cohen, T. Farrah, S. D. Lyman, F. Wagener, R. F. DuBose, R. J. Armitage, and M. K. Spriggs. 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:4015-4021.
60. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, M. Nakamura, and T. Takeshita. 1995. The common gamma-chain for multiple cytokine receptors. Adv. Immunol. 59:225-277.
61. Symons, J. A., J. A. Eastgate, and G. A. Duff. 1990. A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells. Cytokine 2:190-198.
62. Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type 1 interferon receptor of novel structure and broad species specificity. Cell 81:551-560.
63. Vos, J. C., M. Sasker, and H. G. Stunnenberg. 1991. Vaccinia virus capping enzyme is a transcription initiation factor. EMBO J. 10:2553-2558.
64. Yirrell, D. L., H. W. Reid, M. Norval, and H. R. P. Miller. 1991. Qualitative and quantitative changes in ovine afferent lymph draining the site of epidermal orf virus infection. Vet. Dermatol. 2:133-138.
65. Yirrell, D. L., H. W. Reid, M. Norval, G. Entrican, and H. R. P. Miller. 1991. Response of efferent lymph and popliteal lymph node to epidermal infection of sheep with orf virus. Vet. Immunol. Immunopathol. 28:219-235.